Moreover, in iron-deficient patients, the administration of oral iron sulfate causes an increase of serum hepcidin, a hormone blocking ferroportin and protecting against iron overload, that falls to basal levels 48 h after treatment, thus imposing an every-other-day administration schedule for an optimal iron absorption [39]. The gene discussed is SLC40A1; the disease is Tangier disease.